Information about Pentapharma
My details
*
*
*

Pentapharma (SRL)

BE 0666.417.120

Slableedstraat 2E, 8630 Veurne

Company information

Status
Active

Enterprise number

BE0666.417.120

VAT liability
Yes
Established
14-11-2016
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Market research and public opinion polling
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Pentapharma

2024 2023 2022 2021
Profit/Loss € 5,596 954 % € -655 -111 % € 6,079 -64 % € 16,862
Equity € 35,649 19 % € 30,053 -2 % € 30,709 25 % € 24,630
Gross margin € 7,972 21835 % € -37 -101 % € 3,308 -83 % € 19,045

Publications from Pentapharma

Date Publication
25-07-2025 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Miscellaneous - Resignations - Appointments (NL)
18-11-2016 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Pentapharma?
The VAT number of Pentapharma is BE 0666.417.120.
Wat is the PEPPOL ID of Pentapharma?
The PEPPOL ID of Pentapharma is 0208:0666417120. Log in or start a free trial to see the full overview.
When was Pentapharma founded?
Pentapharma was founded on 14-11-2016.
What is the address of Pentapharma?
The current registered office of Pentapharma is located at Slableedstraat 2E, 8630 Veurne.
When was the last time Pentapharma filed their annual financial statements?
The most recent financial statements of Pentapharma were filed on 15-07-2025.
How many employees does Pentapharma have?
There are currently no employees working at Pentapharma or no workforce information is available.
What is the annual turnover of Pentapharma?
At the time of its most recent financial statements, Pentapharma did not publish any turnover figures. Pentapharma reported a gross margin of €7,972.41.

Sources